Table 1.
Included cases
| HS | Cohort | |||||
|---|---|---|---|---|---|---|
| (n) | (%) | CI95 | (n) | (%) | CI95 | |
| Animals (total) | 31 | 33.3 | 23.9–43.9 | 93 | 100 | |
| Mean age ± SD | 8.2 ± 4.9 | 8.0 ± 5.8 | ||||
| Sex distribution | ||||||
| Males | 15 | 48.4 | 30.2–66.9 | 38 | 40.9 | 30.8–51.5 |
| Females | 16 | 51.6 | 33.1–69.8 | 55 | 59.1 | 48.5–69.2 |
| Seizure type | ||||||
| Focal | 1 | 3.2 | 0.08–16.7 | 6 | 6.5 | 2.4–13.5 |
| Focal + generalized | 2 | 6.4 | 0.8–21.4 | 4 | 4.3 | 1.2–10.6 |
| Generalized | 13 | 41.9 | 24.5–60.9 | 51 | 54.8 | 44.2–65.2 |
| Secondary SE | 7 | 22.6 | 9.6–41.1 | 10 | 10.7 | 5.3–18.9 |
| Primary SE | 3 | 9.7 | 2.0–25.7 | 12 | 12.9 | 6.8–21.5 |
| Not defined | 5 | 16.2 | 5.5–33.7 | 10 | 10.8 | 5.3–18.9 |
| Seizure etiology | ||||||
| IC mass | 5 | 16.1 | 5.5–33.7 | 12 | 12.9 | 6.8–21.5 |
| Vascular | 1 | 3.2 | 0.08–16.7 | 8 | 8.6 | 3.8–16.2 |
| Metabolic | 3 | 9.7 | 2.0–25.7 | 8 | 8.6 | 3.8–16.3 |
| Inflammatory | 15 | 48.4 | 3 0.2–66.9 | 28 | 30.1 | 21.0–40.5 |
| Etiol. unknown | 3 | 9.7 | 2.0–25‐7 | 24 | 25.8 | 16.0–35.5 |
| Combined | 4 | 12.9 | 3.6–29.8 | 13 | 14.0 | 7.7–22.7 |
| Time course | ||||||
| <3 weeks | 22 | 71.0 | 52.0–85.8 | 72 | 77.4 | 65.6–85.4 |
| >3 weeks | 9 | 29.0 | 14.2–48.0 | 21 | 22.6 | 14.6–32.4 |
Case numbers, percentages and 95% confidence intervals of all epileptic cats are listed in the right column and of the HS‐positive cats in the left column. Please note, that for better distinction of the etiological groups, the animals with combined pathologies were listed as a separate entity and excluded from the other groups.